No Data
Express News | Shanghai Opm Biosciences Says Key Shareholder Plans to Unload up to 3% Stake From Jan 7 to Apr 6
Private Equity Firms Invested in Shanghai OPM Biosciences Co., Ltd. (SHSE:688293) Copped the Brunt of Last Week's CN¥454m Market Cap Decline
The main shareholder Guoshou Chengda reduced their shareholding in Aupuma (688293.SH) by 1%.
Aoupumai (688293.SH) announced that the company's shareholder with more than 5% ownership, China Life Chengda (Shanghai) Health Industry Equity...
Shanghai OPM Biosciences Co., Ltd. (SHSE:688293) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected
Aupu Mai (688293.SH): Shareholder Shanghai Panxin intends to collectively reduce their shareholding by no more than 3.00%.
On November 4, Gelonhui announced that Opuma (688293.SH) received a "Notice of Shareholders' Shareholding Reduction Plan" from Shanghai Panxin, a shareholder with more than 5% of the shares, on November 3, 2024. Due to the shareholder's own funding needs, Shanghai Panxin plans to reduce the company's shares through block trades and centralized competitive trading from November 26, 2024 to February 22, 2025. The total number of shares to be reduced shall not exceed 3,443,173 shares, with a total reduction ratio not exceeding 3.00% of the company's current total share capital.
Oppo Mai: Oppo Mai: third quarter report 2024
No Data
Boganji4 : can't help me